Astrizi Bio
- Biotech or pharma, therapeutic R&D
Astrizi Bio is a preclinical stage biopharmaceutical company developing innovative, orally available, disease modifying therapeutics for obesity and Parkinson's disease.
We have initiated IND enabling studies on our lead asset and are raising Series A round to advance our obesity asset through Phase 1 and Phase 2a clinical trials.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}